Dr. Shahla Ray

University of Tennessee, USA

Email: [email protected]

Qualifications

1997 Ph.D., Hacettepe University, Turkey

1992 M.Sc., Hacettepe University, Turkey

1982 B.Sc., Ankara University, Turkey

Publications (selected)

1. Kieri, O., Narayanan, A., & Jütte, B. B., et al. (2026). Linking gut microbiome to HIV-1 reservoir size in people living with HIV. Gut Pathogens, 18(1), Article 29.
2. Narayanan, A., Kieri, O., & Vesterbacka, J., et al. (2024). Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV. Scientific Reports, 14(1), Article 17820.
3. Ray, S., Narayanan, A., & Vesterbacka, J., et al. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomes, 9(1), Article 104.
4. Cena-Diez, R., Narayanan, A., & Ray, S., et al. (2023). Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism. International Journal of Antimicrobial Agents, 61(5), Article 106792.
5. Ghorbani, M., Al-Manei, K., & Naud, S., et al. (2023). Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV. Frontiers in Immunology, 13, Article 1079995.
6. Ray, S., Pandey, N. K., & Kushwaha, G. S., et al. (2022). Structural investigation on SPI‐6–associated Salmonella typhimurium VirG‐like stress protein that promotes pathogen survival in macrophages. Protein Science, 31(4), 835–849.
7. Sperk, M., Ambikan, A. T., & Ray, S., et al. (2021). Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist. Journal of Virology, 95(18), Article e00479-21.
8. Bai, X., Narayanan, A., & Nowak, P., et al. (2021). Whole-genome metagenomic analysis of the gut microbiome in HIV-1-infected individuals on antiretroviral therapy. Frontiers in Microbiology, 12, Article 667718.
9. Das, S., & Ray, S., & Arunima, A., et al. (2020). A ROD9 island encoded gene in Salmonella Enteritidis plays an important role in acid tolerance response and helps in systemic infection in mice. Virulence, 11(1), 247–259.
10. Arunima, A., Swain, S. K., & Ray, S., et al. (2020). RpoS-regulated SEN1538 gene promotes resistance to stress and influences Salmonella enterica serovar enteritidis virulence. Virulence, 11(1), 295–314.
11. Ray, S., Narayanan, A., & Giske, C. G., et al. (2020). Altered gut microbiome under antiretroviral therapy: impact of efavirenz and zidovudine. ACS Infectious Diseases, 7(5), 1104–1115.
12. Sperk, M., Ambikan, A., & Ray, S., et al. (2020). Novel mechanism of HIV elite control by enriching gut dipeptides as HIV-1 antagonist but prevotella agonist. bioRxiv. Advance online publication.
13. Das, S., & Ray, S., & Ryan, D., et al. (2018). Identification of a novel gene in ROD9 island of Salmonella Enteritidis involved in the alteration of virulence-associated genes expression. Virulence, 9(1), 348–362.
14. Ray, S., Das, S., & Panda, P. K., et al. (2018). Identification of a new alanine racemase in Salmonella Enteritidis and its contribution to pathogenesis. Gut Pathogens, 10(1), Article 30.
15. Ray, S., Das, S., & Suar, M. (2017). Molecular mechanism of drug resistance. In Drug resistance in bacteria, fungi, malaria, and cancer (pp. 47–110). Springer.
16. Jaiswal, S., Paul, P., & Padhi, C., et al. (2016). The Hha-TomB Toxin-Antitoxin System Shows Conditional Toxicity and Promotes Persister Cell Formation by Inhibiting Apoptosis-Like Death in S. Typhimurium. Scientific Reports, 6(1), Article 38204.
17. Ryan, D., Pati, N. B., & Ojha, U. K., et al. (2015). Global transcriptome and mutagenic analyses of the acid tolerance response of Salmonella enterica serovar Typhimurium. Applied and Environmental Microbiology, 81(23), 8054–8065.
18. Jaiswal, S., Pati, N. B., & Dubey, M., et al. (2015). The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in mice. Gut Pathogens, 7(1), Article 24.
19. Vishwakarma, V., Sahoo, S. S., & Das, S., et al. (2015). Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection. Vaccine, 33(15), 1880–1889.
20. Ray, S., & Suar, M. (2015). Vaccine Nanocarriers: The Future Ahead. In Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering (pp. 22–45). IGI Global.

Profile Details
https://biology.utk.edu/people/shahla-ray/
https://www.researchgate.net/profile/Shahla-Ray

WOS ResearcherID: FWN-3581-2022